Siegrist Jonathan Philip
Known title: EVP of R&D & CTOCIK: 0002040321
Associated companies
Transaction History
| QDEL | ▼ Sell | Tax Withholding | 1,009 | $28K | 1/29/2026 | View on chart |
| QDEL | ▲ Buy | Grant | 2,448 | $0 | 1/29/2026 | View on chart |
| QDEL | ▲ Buy | Grant | 18,656 | $0 | 10/15/2025 | View on chart |
| QDEL | ▼ Sell | Tax Withholding | 6,676 | $182K | 10/15/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
QuidelOrtho Reports Q2 2026 Results and New IR Lead
QuidelOrtho released its second-quarter 2026 earnings, with reports noting that profit margins have recovered while cash levels remain a point of discussion. The company also announced the appointment of Sanjeev Sharma as Vice President of Investor Relations. These updates provide context for the stock's current position within its 52-week range.
QuidelOrtho Reports Q2 2026 Results and New IR Lead. QuidelOrtho released its second-quarter 2026 earnings, with reports noting that profit margins have recovered while cash levels remain a point of discussion. The company also announced the appointment of Sanjeev Sharma as Vice President of Investor Relations. These updates provide context for the stock's current position within its 52-week range.